𝔖 Bobbio Scriptorium

✦ LIBER ✦

AIDS clinical trials group: Phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex

✍ Scribed by Tze-Chiang Meng; Margaret A. Fischl; Douglas D. Richman

Book ID: 115683178
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 575 KB
Volume: 88
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(90)90419-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternating and intermittent regimens of

Alternating and intermittent regimens of zidovudine (3′-azido-3′-deoxythymidine) and dideoxycytidine (2′,3′-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex

✍ Gail Skowron; Thomas C. Merigan 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 442 KB

Safety and tolerance of dideoxycytidine

Safety and tolerance of dideoxycytidine as a single agent: Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex

✍ Thomas C. Merigan; Gail Skowron 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 522 KB

Phase I study of 2′-3′-dideoxyinosine ad

Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine

✍ Kevin J. Connolly; J.Davis Allan; Helen Fitch; Lenore Jackson-Pope; Colin McLare 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 742 KB

Effects of recombinant human granulocyte

Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study

✍ Poll A. Van Der Wouw; Remko Van Leeuwen; Rien H. J. Van Oers; Joep M. A. Lange; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

Study of activated T cell in man: II. In

Study of activated T cell in man: II. Interleukin 2 receptor and transferrin receptor expression on T cells and production of interleukin 2 in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex

✍ Sudhir Gupta 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 535 KB

Randomized phase II studies of VIRACEPTT

Randomized phase II studies of VIRACEPTTM, an HIV protease inhibitor, given as monotherapy and in combination with stavudine (d4T): J. Peterkin1, S. Chapman1, M. Conant2, J. Gathe, Jr.3, P. Hawley4, M. Markowitz5. 1Agouron Pharmaceuticals, Inc., La Jolla, CA; 2Conant Medical Group, San Francisco, CA; 3Montrose Clinic, Houston, TX; 4Whitman-Walker Clinic, Inc., Washington, D.C.; Aaron 5Diamond AIDS Research Center, N.Y.

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 94 KB